Dr. Sissi Lin is an organic chemist with over 15 years of specialized experience in nucleic acid chemistry and RNA drug development. Her career includes serving  as the founding director of Chemistry and Operations at Lerna Biopharma, a Singapore-based biotech company, where she spearheaded the development of oligonucleotide drug technologies and managed CMC for preclinical candidates. Dr. Lin has also served as Vice President and Advisor at Biotech Connection Singapore, where she played an active role in strengthening Singapore's biotech ecosystem. She has been featured at numerous conferences focused on RNA drug development and the biotech sector as a speaker and panelist. Currently, Dr. Lin is the Deputy Director at the Nucleic Acid Therapeutics Initiative, Singapore’s national platform for RNA drug development, where she directs R&D strategy and drives innovations in therapeutic solutions.